Clinical Trial Update: Study in Neuropathic Pain Patients With Peripheral Nerve Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in neuropathic pain due to peripheral nerve injury conducted by GlaxoSmithKline has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Peripheral Nerve Injury

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pain, Neuropathic | Phase 2 | Status: COMPLETED